1. Home
  2. SKIL vs MIRA Comparison

SKIL vs MIRA Comparison

Compare SKIL & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Skillsoft Corp.

SKIL

Skillsoft Corp.

HOLD

Current Price

$7.99

Market Cap

40.2M

Sector

Technology

ML Signal

HOLD

Logo MIRA Pharmaceuticals Inc.

MIRA

MIRA Pharmaceuticals Inc.

HOLD

Current Price

$1.01

Market Cap

43.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SKIL
MIRA
Founded
1998
2020
Country
United States
United States
Employees
2247
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
40.2M
43.7M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
SKIL
MIRA
Price
$7.99
$1.01
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
215.1K
130.1K
Earning Date
04-07-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$0.11
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.43
$0.90
52 Week High
$23.00
$2.45

Technical Indicators

Market Signals
Indicator
SKIL
MIRA
Relative Strength Index (RSI) 63.57 43.00
Support Level $3.63 $0.99
Resistance Level $8.53 $1.24
Average True Range (ATR) 0.99 0.05
MACD 0.10 -0.00
Stochastic Oscillator 77.75 9.94

Price Performance

Historical Comparison
SKIL
MIRA

About SKIL Skillsoft Corp.

Skillsoft Corp is a leader in corporate digital learning. The company's segments include Talent Development Solutions and Global Knowledge. Talent Development Solutions brings a foundation of products and customers. TDS enterprise-grade solution serves customers and employees world-wide. TDS Learner is a world-renowned consumer-scale and experiential learning platform that serves learners internationally. The Global Knowledge segment is centered around instructor-led training, or live learning, with face-to-face delivery by experienced trainers, both in-person and virtually.

About MIRA MIRA Pharmaceuticals Inc.

Mira Pharmaceuticals Inc is a clinical-stage pharmaceutical development company focused on developing novel oral small-molecule therapeutics for neurologic, neuropsychiatric, metabolic, and inflammatory disorders. The company's pipeline includes three product candidates: Ketamir-2, MIRA-55, and SKNY-1, three drug candidates designed to address unmet medical needs across neuropathic and inflammatory pain, central nervous system disorders, and metabolic and behavioral conditions. The company operates as a single operating and reportable segment.

Share on Social Networks: